 Home > Medical News > Medicines Company News > Hengrui's new indication for carrelizumab for injection will be approved soon

Hengrui's new indication for carrelizumab for injection will be approved soon

 Last Update: 2021-07-06
 Source: Internet
 Author: User

Tags

investigational new drug

official royal website

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On June 7, the official website of the State Food and Drug Administration showed that Hengrui's new indication for carrelizumab for injection (registration classification: 2.
2) was already in the "under review" status (acceptance number: CXSS2000055), and it is expected to be obtained soon NMPA approved
.
The indications to be approved this time are: combined cisplatin and gemcitabine for the first-line treatment of patients with locally recurring or metastatic nasopharyngeal carcinoma

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.